← back to search
Iván Bottoli
Novartis (Switzerland) · CH
Area of research
Rheumatology · Physiology
Research interest
Research interests include Medicine, COPD, Sputum, Placebo, Internal medicine, and Cystic fibrosis.
h-index
—
citations
67
works
2
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
Icenticaftor, a CFTR Potentiator, in COPD: A Multicenter, Parallel-Group, Double-Blind Clinical Trial
American Journal of Respiratory and Critical Care Medicine
2023
cited by
43
position: middle
doi
Safety and efficacy of the cystic fibrosis transmembrane conductance regulator potentiator icenticaftor (QBW251)
Journal of Cystic Fibrosis
2020
cited by
24
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Steven M. Rowe
· University of Alabama at Birmingham
1
papers (2020–2020)
Jadwiga A. Wedzicha
· Imperial College London
1
papers (2023–2023)
Robert M. Strieter
· University of Virginia
1
papers (2020–2020)
David J. Rowlands
· Columbia University
1
papers (2020–2020)
—
·
1
papers (2023–2023)
Gerard J. Criner
· Temple University Hospital
1
papers (2023–2023)
Jeroen C. Verheijen
· Novartis (Switzerland)
1
papers (2020–2020)
Christian Bartels
· Novartis (Switzerland)
1
papers (2023–2023)
—
·
1
papers (2023–2023)
—
·
1
papers (2020–2020)
Ieuan Jones
· Novartis (Switzerland)
1
papers (2020–2020)
Frits M.E. Franssen
· University of Aveiro
1
papers (2023–2023)
Jerry A. Nick
· University of Colorado Denver
1
papers (2020–2020)
—
·
1
papers (2020–2020)
Shamsah Kazani
· Novartis (Switzerland)
1
papers (2020–2020)
Martin Gosling
· Novartis (Switzerland)
1
papers (2020–2020)
—
·
1
papers (2023–2023)
—
·
1
papers (2023–2023)
—
·
1
papers (2023–2023)
Joerg H. Eckert
· Novartis (Switzerland)
1
papers (2023–2023)